Healthcare
TABLE-J-Bridge <9318.T>-6mth group results
6 months ended 6 months ended Full year to Full year ended Full Article
UPDATE 2-U.S. FDA tackles gray area of social media
* FDA urged to communicate with Wikipedia, other sites (Recasts more comments from Google, Yahoo, Johnson & Johnson) Full Article
UPDATE 1-Cephalon, Barr settle patent infringement suit
NEW YORK, Nov 12 (Reuters) - Cephalon Inc said on Thursday it has come to an agreement to settle its patent infringement dispute with Barr Pharmaceuticals over the pain drug Fentora. Full Article
UPDATE 1-Medidata Solutions Q3 beats market, raises 2009 outlook
Nov 12 (Reuters) - Software maker Medidata Solutions Inc posted a quarterly profit that handily beat market estimates as revenue from application services jumped 36 percent, and raised its 2009 outlook. Full Article
Canada shrugs off cost of flu vaccination campaign
OTTAWA, Nov 12 (Reuters) - Canada's top medical official defended the national H1N1 vaccination campaign on Thursday, and said the costs of doing nothing would be far higher than the money spent immunizing millions of people. Full Article
New Issue-Zimmer Holdings sells $1 bln in two parts
Nov 12 (Reuters) - Zimmer Holdings Inc on Thursday sold $1 billion of notes in two parts, said IFR, a Thomson Reuters service. Full Article
Zimmer Holdings sells $1 bln debt in 2 parts - IFR
NEW YORK, Nov 12 (Reuters) - Zimmer Holdings Inc on Thursday sold $1 billion of debt in a two-part sale, said IFR, a Thomson Reuters service. Full Article
New Issue-Quest Diagnostics sells $750 mln of notes
Nov 12 (Reuters) - Quest Diagnostics on Thursday sold $750 million of notes in two parts, said IFR, a Thomson Reuters service. Full Article
UPDATE 1-U.S. FDA tackles gray area of social media
* Lilly: hesitant to use social media without FDA clarity Full Article
Zimmer Holdings launches $1 bln 2-part debt sale
NEW YORK, Nov 12 (Reuters) - Zimmer Holdings Inc on Thursday launched a $1.0 billion two-part debt sale, said IFR, a Thomson Reuters service. Full Article
US
UK- Europe
- Asia
- US Most Actives
Hassan sees Merck retaining Remicade
NEW YORK (Reuters) - Fred Hassan, former head of Schering-Plough Corp, said Merck & Co is likely to prevail over Johnson & Johnson in its battle to retain overseas rights to the blockbuster arthritis drug Remicade. Full Article
| Symbol | Last | Net Change |
|---|---|---|
| BRENT CRUDE | $76.50 | $-0.27 |
| MINI SILVER | $0.00 | $0.00 |
| 100 OZ GOLD | $1,106.60 | $0.00 |





